Physician Assistant, Medical · Trumbull, CT
NPI
1669577953
Since 2006
Specialty
Physician Assistant, Medical
Code 363AM0700X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
5520 Park Ave
Trumbull, CT, 06611
Phone (203) 373-7330
Groups this clinician bills Medicare through
Medicare paid, 2024
$106K
2,207 services
Medicare patients, 2024
220
Average age 70
Drug cost, 2024
$634K
8,127 prescriptions
Company payments, 2025
$1,588
From 12 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Maryann Chomiak was code 99213 (office e&m - established), 722 times for 205 patients. In total Maryann Chomiak billed 2,207 services in 14 codes, and Medicare paid $106K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2018-06-26.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 722 | 205 | $55.98 | $40K |
| J1010 Injection, methylprednisolone acetate, 1 mg | Office | 440 | 16 | $0.10 | $45.26 |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 224 | 82 | $43.95 | $9,845 |
| 80307 Drug Tests | Office | 201 | 114 | $59.55 | $12K |
| 99214 Office E&M - Established | Office | 139 | 85 | $84.94 | $12K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 124 | 22 | $0.07 | $9.25 |
| G0481 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 105 | 71 | $152.15 | $16K |
| G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 96 | 68 | $107.48 | $10K |
| 20552 Musculoskeletal | Office | 60 | 41 | $35.10 | $2,106 |
| 99426 Chronic, Principal, and Transitional Care Management | Office | 50 | 17 | $43.69 | $2,185 |
| 99439 Chronic, Principal, and Transitional Care Management | Office | 38 | 28 | $33.91 | $1,289 |
By year: 2022 $109K for 1,778 services; 2023 $53K for 878 services; 2024 $106K for 2,207 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 80307 Drug Tests | 201 | 114 | $59.55 | $12K |
| G0481 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 105 | 71 | $152.15 | $16K |
| G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 96 | 68 | $107.48 | $10K |
Medicare prescription drug claims, 2024
In 2024, the drug Maryann Chomiak prescribed most often to Medicare patients was Oxycodone Hcl, with 1,481 prescriptions and refills. In total Maryann Chomiak wrote 8,127 Medicare prescriptions that cost $634K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Oxycodone Hcl Generic | 1,481 | 1,482 | 286 | $28K |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 634 | 635 | 141 | $20K |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 517 | 517 | 119 | $14K |
| Gabapentin Generic | 441 | 499 | 122 | $6,462 |
| Lidocaine Generic | 405 | 429 | 115 | $27K |
| Cyclobenzaprine Hcl Generic | 353 | 361 | 108 | $30K |
| Morphine Sulfate Er Morphine Sulfate | 352 | 352 | 85 | $6,358 |
| Tizanidine Hcl Generic | 350 | 373 | 96 | $3,677 |
| Diclofenac Sodium Generic | 225 | 230 | 74 | $6,394 |
| Celecoxib Generic | 187 | 207 | 51 | $4,029 |
| Pregabalin Generic | 167 | 193 | 47 | $5,135 |
| Diazepam Generic | 156 | 156 | 43 | $526 |
| Methocarbamol Generic | 146 | 150 | 39 | $1,835 |
| Meloxicam Generic | 143 | 171 | 45 | $408 |
| Tramadol Hcl Generic | 142 | 142 | 49 | $1,707 |
Brand drugs: 788 claims; generic drugs: 7,339 claims; opioid claims: 3,746.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Maryann Chomiak $1,588 ($1,588 in general payments such as food, travel and fees) from 12 companies. The largest payer was Salix Pharmaceuticals, a division of Bausch Health US, LLC with $443.
| Company | Payments | Amount |
|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 47 | $443 |
| Collegium Pharmaceutical, Inc. COLL | 33 | $429 |
| Scilex Pharmaceuticals Inc. | 9 | $181 |
| TerSera Therapeutics LLC | 3 | $94.45 |
| Pfizer Inc. PFE | 4 | $91.67 |
| Abbvie Inc. ABBV | 3 | $72.54 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 3 | $72.2 |
| Axsome Therapeutics, Inc. AXSM | 2 | $61.47 |
| Lundbeck LLC | 2 | $53.34 |
| Valinor Pharma, LLC | 2 | $41.28 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.